These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35199189)

  • 1. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.
    Poon DMC; Yang B; Geng H; Wong OL; Chiu ST; Cheung KY; Yu SK; Chiu G; Yuan J
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):841-850. PubMed ID: 35199189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test.
    Han EY; Wang H; Briere TM; Yeboa DN; Boursianis T; Kalaitzakis G; Pappas E; Castillo P; Yang J
    J Appl Clin Med Phys; 2022 Mar; 23(3):e13518. PubMed ID: 34994101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing adaptation strategies in MRI-guided online adaptive radiotherapy for prostate cancer: Implications for treatment margins.
    Dassen MG; Janssen T; Kusters M; Pos F; Kerkmeijer LGW; van der Heide UA; van der Bijl E
    Radiother Oncol; 2023 Sep; 186():109761. PubMed ID: 37348607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy.
    Sandoval ML; Rishi A; Latifi K; Grass GD; Torres-Roca J; Rosenberg SA; Yamoah K; Johnstone PAS
    Cancer Control; 2024; 31():10732748241270595. PubMed ID: 39206515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an MR-driven dose-of-the-day procedure for online adaptive radiotherapy in upper gastrointestinal cancer patients.
    Semeniuk O; Shessel A; Velec M; Fodor T; Rocca CC; Barry A; Lukovic J; Yan M; Mesci A; Kim J; Wong R; Dawson LA; Hosni A; Stanescu T
    Phys Med Biol; 2024 Aug; 69(16):. PubMed ID: 39048106
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors.
    Lee HY; Lee G; Ferguson D; Hsu SH; Hu YH; Huynh E; Sudhyadhom A; Williams CL; Cagney DN; Fitzgerald KJ; Kann BH; Kozono D; Leeman JE; Mak RH; Han Z
    Biomed Phys Eng Express; 2024 Jun; 10(4):. PubMed ID: 38861951
    [No Abstract]   [Full Text] [Related]  

  • 11. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of adaptive strategies based on deformation vector field features for MR-guided adaptive radiotherapy of prostate cancer.
    Xia WL; Liang B; Men K; Zhang K; Tian Y; Li MH; Lu NN; Li YX; Dai JR
    Med Phys; 2023 Jun; 50(6):3573-3583. PubMed ID: 36583878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experiences with a high field 1.5 T MR linac.
    Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
    Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosimetric analysis of MR-LINAC treatment plans for salvage spine SBRT re-irradiation.
    Han EY; Yeboa DN; Briere TM; Yang J; Wang H
    J Appl Clin Med Phys; 2022 Oct; 23(10):e13752. PubMed ID: 36004700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
    BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer.
    de Leon J; Jelen U; Carr M; Crawford D; Picton M; Tran C; McKenzie L; Peng V; Twentyman T; Jameson MG; Batumalai V
    Radiother Oncol; 2024 Nov; 200():110527. PubMed ID: 39242030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study of Stereotactic Body Radiotherapy (SBRT) with Concomitant Whole-Pelvic Radiotherapy (WPRT) for High-Risk Localized Prostate Cancer Patients Using 1.5 Tesla Magnetic Resonance Guidance: The Preliminary Clinical Outcome.
    Poon DMC; Yuan J; Yang B; Wong OL; Chiu ST; Chiu G; Cheung KY; Yu SK; Yung RWH
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.